AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 70 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.08 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,707,000 | +22.8% | 281,679 | +6.0% | 0.01% | 0.0% |
| Q1 2020 | $3,833,000 | -32.3% | 265,832 | +57.2% | 0.01% | -20.0% |
| Q4 2019 | $5,661,000 | -15.5% | 169,132 | -47.2% | 0.01% | +42.9% |
| Q3 2019 | $6,702,000 | +387.8% | 320,084 | +385.0% | 0.01% | +133.3% |
| Q2 2019 | $1,374,000 | -89.2% | 65,999 | -92.1% | 0.00% | -94.0% |
| Q2 2016 | $12,757,000 | +762.0% | 831,093 | +798.5% | 0.05% | +614.3% |
| Q1 2016 | $1,480,000 | -13.3% | 92,500 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $1,707,000 | -12.0% | 92,500 | +20.8% | 0.01% | -22.2% |
| Q3 2015 | $1,940,000 | – | 76,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
| Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
| Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
| Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
| Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
| RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
| Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
| Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
| ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
| Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |